A Study to Collect Data on the Use of Eylea in Babies Born Too Early Who Have a Condition of the Eye Where Blood Vessels Grow Abnormally in the Retina (Retinopathy of Prematurity)
Clinical trial NCT05705258 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05705258
- Sponsor
- Bayer
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-27
- Primary completion
- 2026-02-06
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.